Natus Medical Inc's ability to collect accounts receivable sequentially worsen to 4.72, indicating more challenging environment then in the fourth quarter 2021, but still, it is a far cry from any concerns. Natus Medical Inc's Accounts Receivable average collection period in the Mar 31 2022 quarter, has increased to 77 days, from 76 days, in the Dec 31 2021 quarter.

If we take a look into Healthcare sector 517 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2022 from 1215 to 3167.

What is Receivable Turnover Ratio?
What is Natus Medical Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NTUS Receivables Turnover Ratio	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter	(Mar 31 2021) I. Quarter
Y / Y Receivable Change	13.56 %	1698.81 %	15.77 %	3.99 %	-9.77 %
Y / Y Revenue Change	4.23 %	8.37 %	10.77 %	36.8 %	5.07 %
Receivable Turnover Ratio (TTM)	4.72	4.82	6.44	6.59	6.22
NTUS's Total Ranking	# 3167	# 1215	# 1194	# 3019	# 2779
Accounts Receivable average collection period days	77	76	57	55	59
Seq. Receivable Change	-7.2 %	14.78 %	4.93 %	1.61 %	1369.92 %
Seq. Revenue Change	-6.89 %	12.98 %	-1.81 %	0.91 %	-3.19 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 173
Healthcare Sector	# 518
Overall Market	# 3167

Receivable Turnover Ratio Statistics
High	Average	Low
6.59	4.62	3.86
(Jun 30 2021)		(Jun 30 2013)

NTUS Company Profile • Back to NTUS Efficiency Comparisons • Compare NTUS Receivables Turnover Ratio to its Competitors

Financial Statements
Natus Medical Inc's Accounts Receivable	$ 104 Millions	Visit NTUS's Balance sheet
Natus Medical Inc's Sales TTM	$ 478 Millions	Visit NTUS's Income Statement
Sources of NTUS's Revenues		Visit NTUS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NTUS's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NTUS's Growth Rates	NTUS's Roa	NTUS's Inventory Turnover Ratio	NTUS's Dividend Comparisons
NTUS's Profitability Ratios	NTUS's Roi	NTUS's Asset Turnover Ratio	NTUS's Dividend Growth
NTUS's Valuation Ratios	NTUS's Roe	NTUS's Financial Strength Ratios	NTUS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2022	Receivable at quarter ending Mar 31 2022
Regenxbio Inc	12.64	$ 473.681 Millions	$ 37.468 Millions
Solana Company	12.56	$ 0.628 Millions	$ 0.050 Millions
Ultragenyx Pharmaceutical Inc	12.42	$ 331.946 Millions	$ 26.726 Millions
Alpha Pro Tech Ltd	12.21	$ 63.137 Millions	$ 5.170 Millions
Tango Therapeutics Inc	12.14	$ 36.414 Millions	$ 3.000 Millions
Semler Scientific inc	12.13	$ 53.860 Millions	$ 4.440 Millions
Celularity Inc	12.09	$ 24.610 Millions	$ 2.036 Millions
Biomerica Inc	12.08	$ 14.623 Millions	$ 1.210 Millions
Lifeloc Technologies Inc	12.04	$ 7.406 Millions	$ 0.615 Millions
Clearside Biomedical Inc	11.96	$ 29.888 Millions	$ 2.500 Millions
Teladoc Health Inc	11.95	$ 2,144.382 Millions	$ 179.498 Millions
Caremax Inc	11.68	$ 404.765 Millions	$ 34.650 Millions
Clene Inc	11.68	$ 0.540 Millions	$ 0.046 Millions
Viveve Medical Inc	11.67	$ 6.617 Millions	$ 0.567 Millions
Cano Health Inc	11.66	$ 1,983.989 Millions	$ 170.158 Millions
Finch Therapeutics Group Inc	11.55	$ 15.333 Millions	$ 1.328 Millions
Quanterix Corporation	11.55	$ 112.899 Millions	$ 9.778 Millions
Abiomed Inc	11.54	$ 1,031.753 Millions	$ 89.443 Millions
Icu Medical Inc	11.30	$ 1,541.384 Millions	$ 136.404 Millions
Imac Holdings Inc	11.21	$ 15.217 Millions	$ 1.358 Millions
National Healthcare Corp	11.17	$ 1,102.312 Millions	$ 98.676 Millions
Integrated Biopharma Inc	11.16	$ 60.037 Millions	$ 5.381 Millions
Karyopharm Therapeutics Inc	11.14	$ 234.229 Millions	$ 21.032 Millions
Zosano Pharma Corporation	11.12	$ 0.659 Millions	$ 0.059 Millions
Mirum Pharmaceuticals Inc	11.10	$ 32.030 Millions	$ 2.885 Millions
Conformis inc	10.96	$ 101.576 Millions	$ 9.266 Millions
Inogen Inc	10.96	$ 351.456 Millions	$ 32.072 Millions
Aridis Pharmaceuticals Inc	10.89	$ 2.722 Millions	$ 0.250 Millions
Lensar Inc	10.72	$ 36.756 Millions	$ 3.429 Millions
Nascent Biotech Inc	10.67	$ 2.000 Millions	$ 0.188 Millions

Date modified: 2026-10-07T00:41:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.